Lyon (1)

Primary Cancer (1)

Recurrent Cancer (1)

Second Cancer (1)

Not yet recruiting (1)

phase 2 (1)

Centre Leon Berard (1)

GlaxoSmithKline (1)

dostarlimab (1)

drug (1)

Other (1)

Interventional (1)

primary cancer

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Not yet recruiting

May 12, 2023